Dutch research institutions and Elsevier form novel Open Science partnership

The Association of Universities in the Netherlands (VSNU), The Netherlands Federation of University Medical Centres (NFU), The Dutch Research Council (NWO) and Elsevier, a global leader in research publishing and information analytics, have formed a novel partnership that includes publishing and reading services as well as the joint development of new open science services for  disseminating and evaluating knowledge. The partnership runs until 31 December 2024.

In December 2019, the research institutions and Elsevier signed a framework agreement. During the past four months, both parties carefully developed this into a unique agreement. In parallel the Dutch Research Institutions established an independent expert Taskforce on responsible management of research information and data to determine the conditions and rules under which metadata of public research output can be (re)used and enriched by all public and private organizations. Following the advice of the Taskforce, a set of collaboration principles was agreed, including data ownership (researchers and/or institutions own their own research data), enduring access to data and metadata, vendor neutrality, interoperability, and institutional discretion on the use of the services.

This has led to the agreement that VSNU, NFU, NWO and Elsevier are pleased to announce today, and which comprises:

  1. Open Access Publishing and Reading services. This is a national deal that covers reading rights to quality, peer-reviewed content across Elsevier’s extensive portfolio of journals and supports the aim of 100% open access publishing for all members of the consortium. From today, 95% of Dutch articles published in Elsevier journals can be made immediately open access through this agreement. The vast majority of Elsevier’s journals already offer an immediate open access option and, as part of this agreement, the company has committed to work towards immediate open access options across all remaining titles.
  2. Open Science Services for Research Intelligence and Scholarly communication. Elsevier will work with the Dutch partners to co-develop new services that help disseminate and evaluate knowledge. The parties will undertake a number of pilot projects to refine and adapt these services to meet the needs of the Dutch Research Institutions and to support the broader ambition of public engagement with science. These pilots will be conducted according to the collaboration principles as mentioned above.

Chief-negotiator/President of Delft University of Technology Tim van der Hagen said: “This deal is a breakthrough in our ambition for 100% open access in the Netherlands and a prelude to a public knowledge base for information about scientific output.”

Enabling Open Access to research results has been a core mission for NWO since 2003. This agreement is a giant step in our collective ambition to provide 100% Open Access for all publicly funded research in the Netherlands. It is fully aligned with the principles of Plan S and a major breakthrough for open science in general.”

Stan Gielen, NWO President

NFU / CEO of Amsterdam UMC Hans Romijn, said: “This is definitely a game changing agreement in open access publishing in medicine from both national and international perspectives, considering the large impact and the volume of Elsevier journals. This will certainly contribute considerably to the advancement of research, and, most importantly, better treatments for our patients.”

This agreement, the first of its kind globally, is a testament to the forward-thinking nature of the Dutch research community. We are delighted to partner with the Dutch community in advancing science and health outcomes through more open, reproducible and collaborative scholarly communication and knowledge systems.”

Kumsal Bayazit, CEO of Elsevier

Philippe Terheggen, Managing Director, Elsevier Journals, added: “This collaboration underscores our firm commitment to open and frictionless access to knowledge by everyone. Almost all our journals already offer immediate open access options and we are working to find a sustainable path for extending this to all our titles.”

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elsevier. (2020, May 20). Dutch research institutions and Elsevier form novel Open Science partnership. News-Medical. Retrieved on December 28, 2024 from https://www.news-medical.net/news/20200520/Dutch-research-institutions-and-Elsevier-form-novel-Open-Science-partnership.aspx.

  • MLA

    Elsevier. "Dutch research institutions and Elsevier form novel Open Science partnership". News-Medical. 28 December 2024. <https://www.news-medical.net/news/20200520/Dutch-research-institutions-and-Elsevier-form-novel-Open-Science-partnership.aspx>.

  • Chicago

    Elsevier. "Dutch research institutions and Elsevier form novel Open Science partnership". News-Medical. https://www.news-medical.net/news/20200520/Dutch-research-institutions-and-Elsevier-form-novel-Open-Science-partnership.aspx. (accessed December 28, 2024).

  • Harvard

    Elsevier. 2020. Dutch research institutions and Elsevier form novel Open Science partnership. News-Medical, viewed 28 December 2024, https://www.news-medical.net/news/20200520/Dutch-research-institutions-and-Elsevier-form-novel-Open-Science-partnership.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elsevier makes all content on COVID-19 Information Center available to PubMed Central